Advancing cancer immunotherapy research
- Mechanistic and biomarker endpoints
- Scientific advice and technical support
CIO-IAL is part of Cancer Immune Monitoring and Analysis Centers (CIMAC), an NCI-sponsored Immuno-Oncology Biomarkers Network
Detection of CD8 cytotoxic cells producing Granzyme B and Perforin (2 day incubation with anti-CD3/anti-CD28 Dynabeads)
Immune phenotype analysis of PBMCs incubated for 4 days with anti-CD3/anti-CD28 Dynabeads. Measured by mass cytometry (CyTOF) (viSNE graphs by Cytobank)
CIO-IAL is part of Cancer Immune Monitoring and Analysis Centers (CIMAC), an NCI-sponsored Immuno-Oncology Biomarkers Network